DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells

Cell Death and Differentiation

Volumn 14, Issue 3, 2007, Pages 548-558

  Katayama, M ^a   Kawaguchi, T ^a   Berger, M S ^a   Pieper, R O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; ADENOSINE TRIPHOSPHATE; ANTIINFECTIVE AGENT; ETOPOSIDE; GLUCOSE; OLIGOMYCIN; TEMOZOLOMIDE;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL SURVIVAL; CYTOTOXICITY; DNA DAMAGE; DRUG MECHANISM; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL DEATH; CELL LINE, TUMOR; DACARBAZINE; DNA DAMAGE; ETOPOSIDE; GLIOMA; HUMANS; MEMBRANE PROTEINS; OXIDATION-REDUCTION; PHOSPHORYLATION;

EID: 33847008972     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402030     Document Type: Article

References (27)

1. Yorimitsu T, Klionsky DJ. Autophagy: Molecular machinery for self-eating. Cell Death Differ 2005; 12 (Suppl 2): 1542-1552.
2. Lum JJ, DeBerardinis RJ, Thompson CB. Autophagy in metazoans: Cell survival in the land of plenty. Nat Rev Mol Cell Biol 2005; 6: 439-448.
3. Levine B, Yuan J. Autophagy in cell death: An innocent convict? J Clin Invest 2005; 115: 2679-2688.
4. Petiot A, Pattingre S, Arico S, Meley D, Codogno P. Diversity of signaling controls of macroautophagy in mammalian cells. Cell Struct Funct 2002; 27: 431-441.
5. Ogier-Denis E, Codogno P. Autophagy: A barrier or an adaptive response to cancer. Biochim Biophys Acta 2003; 1603: 113-128.
6. Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18: 1926-1945.
7. Brown EJ, Schreiber SL. A signaling pathway to translational control. Cell 1996; 86: 517-520.
8. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5: 726-734.
9. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-996.
10. Tentori L, Lacal PM, Benincasa E, Franco D, Faraoni I, Bonmassar E et al. Role of wildtype p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-ribose) polymerase. J Pharmacol Exp Ther 1998; 285: 884-893.
11. Hirose Y, Berger MS, Pieper RO. Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells. Cancer Res 2001; 61: 5843-5849.
12. Hirose Y, Berger MS, Pieper RO. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res 2001; 61: 1957-1963.
13. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 2004; 11: 448-457.
14. Kanzawa T, Bedwell J, Kondo Y, Kondo S, Germano IM. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide. J Neurosurg 2003; 99: 1047-1052.
15. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120: 237-248.
16. Vander Heiden MG, Chandel NS, Schumacker PT, Thompson CB. Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol Cell 1999; 3: 159-167.
17. Allan EH, Chisholm AB, Titheradge MA. Hormonal stimulation of mitochondrial pyruvate carboxylation in filipin-treated hepatocytes. Biochem J 1983; 212: 417-426.
18. Shintani T, Klionsky DJ. Autophagy in health and disease: A double-edged sword. Science 2004; 306: 990-995.
19. Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, Vandenabeele P et al. Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2005; 12 (Suppl 2): 1463-1467.
20. Tsujimoto Y, Shimizu S. Another way to die: Autophagic programmed cell death. Cell Death Differ 2005; 12 (Suppl 2): 1528-1534.
21. Cotran R, Kumar V, Collins T. Cellular injury and adaptation In Coltran R, Kumar V, Collins T, (eds), Robbins Pathologic Basis of Disease 6th edn W.B. Saunders Company: Philadelphia, PA, USA, 1999; pp. 1-37.
22. van Vugt MA, Bras A, Medema RH. Restarting the cell cycle when the checkpoint comes to a halt. Cancer Res 2005; 65: 7037-7040.
23. Hirose Y, Katayama M, Mirzoeva OK, Berger MS, Pieper RO. Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence. Cancer Res 2005; 65: 4861-4869.
24. Tanida I, Minematsu-Ikeguchi N, Ueno T, Kominami E. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 2005; 1: 84-91.
25. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: A molecular definition. Oncogene 2004; 23: 2825-2837.
26. Roninson IB, Broude EV, Chang BD. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist 2001; 4 (Update): 303-313.
27. Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004; 304: 1500-1502.